Anteris Technologies Global Corp. Common Stock

Day range

$5.74 – $5.92

Open

$5.85

Prev close

$5.87

Volume

318.24K

Market cap

$572.08M

Shares out

97.46M

P/E

—

P/S

255.17

P/B

2.28

P/FCF

—

ROE

-41.2%

ROA

-38.0%

Debt/Equity

0.00

Div yield

0.00%

As of Oct 23, 2026

• Supply or distribution agreementSep 23, 2026

  On September 22, 2026, Anteris Aus Operations Pty Ltd ("AAOPL"), a wholly owned subsidiary of Anteris Technologies Global Corp., and Harvey Industries Group Pty Ltd ... entered into an Amendment ... to that certain Supply & Quality Agreement ... The Amendment extends the term of the Agreement for a term expiring on the earlier of (i) December 31, 2026 and (ii) the date of execution of a separate supply and quality agreement between the Parties that is intended to replace the Agreement.

• Executive compensation changeSep 17, 2026

  On September 12, 2026, the Company approved a contingent grant of 1,200,000 nonqualified employee stock options for Wayne Paterson ... and 414,000 nonqualified employee stock options for David St Denis ... with a grant date of September 13, 2026, an exercise price equal to the fair market value of a share of the Company's common stock on the grant date, and an expiration date of September 13, 2036.

• Executive compensation changeSep 8, 2026

  The employment agreement provides for an annual base salary of $475,000, a short-term target annual bonus opportunity of up to 50% of his base salary, eligibility for long-term incentive compensation including a 2026 award with a total target value of $500,000, and other senior executive benefits. The Committee also approved nonqualified stock options with a target value of $500,000, generally vesting in substantially equal installments over three years.

• Underwriting agreementMay 22, 2026

  Subject to the terms and conditions of the Agreement, TD Cowen has agreed to use its commercially reasonable efforts, consistent with its normal trading and sales practices and applicable law and regulations and the rules of the Nasdaq Stock Market LLC, and the Australian Securities Exchange, to sell from time to time the Common Stock so designated by the Company, acting as agent and/or as principal. The Agreement provides that the commission payable to TD Cowen for sales of Common Stock with respect to which TD Cowen acts as sales agent shall be 3.0% of the gross proceeds from the sale of such Common Stock sold pursuant to the Agreement.

• Director appointmentMay 13, 2026

  On May 11, 2026 (May 12, 2026 in Australia), the Board of Directors (the "Board") of Anteris Technologies Global Corp. (the "Company") appointed Ms. Susan Knight and Mr. Stephen Denaro to serve on the Board. Ms. Knight will serve as a Class I Director, with a term expiring at the Company's 2028 annual meeting of stockholders and will serve on the Audit and Risk Committee of the Board. Mr. Denaro will serve as a Class II Director, with a term expiring at the Company's 2026 annual meeting of stockholders.

Days to cover

7.7

Short interest

6.67M

Avg volume

871.51K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Anteris Advances Global PARADIGM Trial Expansion with German Regulatory Clearance
  positiveGlobeNewswire Inc.· Oct 19, 2026
• Anteris to Present at September Healthcare Investor Conferences
  positiveGlobeNewswire Inc.· Aug 31, 2026
• Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance
  positiveGlobeNewswire Inc.· Jun 8, 2026
• Anteris Announces Results for the First Quarter of 2026
  positiveGlobeNewswire Inc.· May 12, 2026
• Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial
  positiveGlobeNewswire Inc.· Apr 28, 2026